» Articles » PMID: 32142528

Risk Factors for Bronchiolitis Hospitalization in Infants: A French Nationwide Retrospective Cohort Study over Four Consecutive Seasons (2009-2013)

Overview
Journal PLoS One
Date 2020 Mar 7
PMID 32142528
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Large studies are needed to update risk factors of bronchiolitis hospitalization. We performed a nationwide analysis of hospitalization rates for bronchiolitis over four consecutive bronchiolitis seasons to identify underlying medical disorders at risk of bronchiolitis hospitalization and assess their frequency.

Methods: Data were retrieved from the French National Hospital Discharge database. Of all infants discharged alive from maternity wards from January 2008 to December 2013 in France (N = 3,884,791), we identified four consecutive cohorts at risk of bronchiolitis during the seasons of 2009-2010 to 2012-2013. The main outcome was bronchiolitis hospitalization during a season. Individual risk factors were collected.

Results: Among infants, 6.0% were preterm and 2.0% had ≥1 chronic condition including 0.2% bronchopulmonary dysplasia (BPD) and 0.2% hemodynamically significant congenital heart disease (HS-CHD). Bronchiolitis hospitalization rates varied between seasons (min: 1.26% in 2010-2011; max: 1.48% in 2012-2013; p<0.001). Except omphalocele, the following conditions were associated with an increased risk for bronchiolitis hospitalization: solid organ (9.052; 95% CI, 4.664-17.567) and stem cell transplants (6.012; 95% CI, 3.441-10.503), muscular dystrophy (4.002; 95% CI, 3.1095-5.152), cardiomyopathy (3.407; 95% CI, 2.613-4.442), HS-CHD (3.404; 95% CI, 3.153-3.675), congenital lung disease and/or bronchial abnormalities, Down syndrome, congenital tracheoesophageal fistula, diaphragmatic hernia, pulmonary hypertension, chromosomal abnormalities other than Down syndrome, hemodynamically non-significant CHD, congenital abnormalities of nervous system, cystic fibrosis, cleft palate, cardiovascular disease occurring during perinatal period, and BPD.

Conclusion: Besides prematurity, BPD, and HS-CHD, eighteen underlying conditions were associated with a significant increased risk for bronchiolitis hospitalization in a nationwide population.

Citing Articles

Burden and seasonality of RSV bronchiolitis in hospitalized children on a French Caribbean island: Practical lessons from a 13-year study.

Flechelles O, Oger C, Charollais A, Drame M, Banydeen R, Najioullah F J Med Virol. 2024; 96(11):e70006.

PMID: 39529469 PMC: 11600485. DOI: 10.1002/jmv.70006.


Hospitalization Trends for Airway Infections and In-Hospital Complications in Cleft Lip and Palate.

Laager R, Gregoriano C, Hauser S, Koehler H, Schuetz P, Mueller B JAMA Netw Open. 2024; 7(9):e2428077.

PMID: 39264632 PMC: 11393727. DOI: 10.1001/jamanetworkopen.2024.28077.


Establishment and Validation of a Risk Prediction Model for Non-Invasive Ventilation Failure After Birth in Premature Infants with Gestational Age < 32 Weeks.

Shen F, Yu M, Rong H, Guo Y, Zou Y, Cheng R Lung. 2024; 202(5):543-552.

PMID: 38958717 DOI: 10.1007/s00408-024-00727-w.


Intubation at Birth Is Associated with Death after Pulmonary Hemorrhage in Very Low Birth Weight Infants.

Sun Y, Qin H, Feng Y, Zou Y, Liu Y, Cheng R Children (Basel). 2024; 11(6).

PMID: 38929201 PMC: 11201528. DOI: 10.3390/children11060621.


Stakeholders' perspectives on clinical trial acceptability and approach to consent within a limited timeframe: a mixed methods study.

Deja E, Donohue C, Semple M, Woolfall K BMJ Open. 2024; 14(1):e077023.

PMID: 38167280 PMC: 10773389. DOI: 10.1136/bmjopen-2023-077023.


References
1.
Che D, Nicolau J, Bergounioux J, Perez T, Bitar D . [Bronchiolitis among infants under 1 year of age in France: epidemiology and factors associated with mortality]. Arch Pediatr. 2012; 19(7):700-6. DOI: 10.1016/j.arcped.2012.04.015. View

2.
Paes B, Fauroux B, Figueras-Aloy J, Bont L, Checchia P, Simoes E . Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease. Infect Dis Ther. 2016; 5(4):453-471. PMC: 5125140. DOI: 10.1007/s40121-016-0137-7. View

3.
Pignotti M, Leo M, Pugi A, De Masi S, Biermann K, Galli L . Consensus conference on the appropriateness of palivizumab prophylaxis in respiratory syncytial virus disease. Pediatr Pulmonol. 2016; 51(10):1088-1096. DOI: 10.1002/ppul.23561. View

4.
Florin T, Plint A, Zorc J . Viral bronchiolitis. Lancet. 2016; 389(10065):211-224. PMC: 6765220. DOI: 10.1016/S0140-6736(16)30951-5. View

5.
Figueras-Aloy J, Manzoni P, Paes B, Simoes E, Bont L, Checchia P . Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Preterm Infants Without Chronic Lung Disease or Congenital Heart Disease. Infect Dis Ther. 2016; 5(4):417-452. PMC: 5125133. DOI: 10.1007/s40121-016-0130-1. View